Loading...
Market
What will be the impact on Quest Diagnostics' Q1 2025 revenue due to the acquisition?
2
Resolution / Starting Odds
Increase by 5% or more • 33%
Fluctuate within ±5% • 33%
Decrease by 5% or more • 33%
Quest Diagnostics' quarterly financial reports
Story
Quest Diagnostics to Acquire LifeLabs for $985 Million (C$1.35 Billion)
Jul 3, 2024, 12:56 PM
Quest Diagnostics has announced its acquisition of LifeLabs, a Canadian provider of community laboratory tests, from OMERS for approximately $985 million, including debt. The deal, valued at C$1.35 billion, will enhance diagnostic services in Canada. The acquisition was officially announced on July 3, 2024. Quest Diagnostics trades under the ticker symbol $DGX.
View original story
Similar markets
Increase by more than 10% • 25%
Increase by 5-10% • 25%
Increase by less than 5% • 25%
No increase or decrease • 25%
Increase by more than 10% • 25%
Increase by 5-10% • 25%
Increase by less than 5% • 25%
No significant increase • 25%
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%
Significant decline in revenue • 25%
Minor decline in revenue • 25%
No change in revenue • 25%
Increase in revenue • 25%
Significant growth (>10%) • 25%
Moderate growth (5-10%) • 25%
Minimal growth (<5%) • 25%
No growth or decline • 25%
Below $2.4 billion • 25%
$2.4 billion to $2.5 billion • 25%
$2.5 billion to $2.6 billion • 25%
Above $2.6 billion • 25%
Less than $90 billion • 25%
$90 billion to $95 billion • 25%
$95 billion to $100 billion • 25%
More than $100 billion • 25%
Less than 10% • 25%
Between 10% and 15% • 25%
Between 15% and 20% • 25%
More than 20% • 25%
Growth above 10% • 25%
Growth 5-10% • 25%
Growth below 5% • 25%
No growth • 25%
Below $8 billion • 25%
$8 billion to $10 billion • 25%
$10 billion to $12 billion • 25%
Above $12 billion • 25%
Less than 3% • 25%
3% to 4% • 25%
4% to 5% • 25%
More than 5% • 25%